论文部分内容阅读
支气管哮喘被视为难治性顽固疾病,迄今仍无理想疗法,鉴此于1979年对应用解痉、抗炎、脱敏、清除病灶等方法治疗无效的病例,进行了人胚胸腺移植,经多年随访证明疗效满意。1985年起对此病者的免疫学、肺功能、微循环等进行了检测。现就1987年10～1992年6月资料完整的47例进行1年4个月～4年8个月的随访,再次证实疗效确切,现报告如下。 资料与方法 一、一般资料:本组男31例,女16例,年龄4～64岁,≤15岁27例(57.46％),≥16岁20例。
Bronchial asthma is regarded as intractable refractory disease, so far there is no ideal therapy. In view of this, in 1979 the application of antispasmodic, anti-inflammatory, desensitization, clear lesions and other methods of treatment ineffective cases of human embryonic thymus transplantation, after years Follow-up proved satisfactory results. Since 1985, the patient’s immunology, lung function, microcirculation were detected. Now 1987 10 ~ June 1992 data complete 47 cases of 1 year and 4 months to 4 years and 8 months of follow-up, once again confirmed the exact effect, are as follows. Materials and Methods First, the general information: The group of 31 males and 16 females, aged 4 to 64 years, ≤ 15 years in 27 cases (57.46%), ≥ 16 years old in 20 cases.